Variant report

Variant	nsv1043957
Chromosome Location	chr14:21363336-21421088
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr14:21387196-21387557	Hela-S3	cervix:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
2	CEBPB	chr14:21387233-21387541	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
3	CEBPB	chr14:21387184-21387565	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
4	CEBPB	chr14:21387140-21387598	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
5	CEBPB	chr14:21390705-21391054	MCF-7	breast:	n/a	n/a
6	CEBPB	chr14:21390806-21390847	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr14:21387301-21387487	K562	blood:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
8	CEBPB	chr14:21387278-21387542	IMR90	lung:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
9	CEBPB	chr14:21373948-21374221	HepG2	liver:	n/a	chr14:21374057-21374070
10	CEBPB	chr14:21390663-21390987	HepG2	liver:	n/a	n/a
11	CEBPB	chr14:21390675-21390974	A549	lung:	n/a	n/a
12	CEBPB	chr14:21387189-21387569	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
13	CEBPB	chr14:21387197-21387553	H1-hESC	embryonic stem cell:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
14	CEBPB	chr14:21390712-21390883	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr14:21404892-21405089	MCF-7	breast:	n/a	n/a
16	CEBPB	chr14:21404946-21405126	K562	blood:	n/a	n/a
17	CEBPB	chr14:21387328-21387608	MCF-7	breast:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
18	CEBPB	chr14:21387183-21387567	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
19	CEBPB	chr14:21387199-21387544	A549	lung:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
20	CEBPB	chr14:21387296-21387479	HepG2	liver:	n/a	chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387368-21387377 chr14:21387366-21387379 chr14:21387368-21387377
21	CEBPB	chr14:21390780-21390974	K562	blood:	n/a	n/a
22	CEBPB	chr14:21404959-21405123	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr14:21372661-21372946	H1-hESC	embryonic stem cell:	n/a	n/a
24	CEBPD	chr14:21387228-21387447	HepG2	liver:	n/a	chr14:21387366-21387377 chr14:21387368-21387377
25	CTCF	chr14:21402360-21402510	BE2_C	brain:	n/a	n/a
26	CTCF	chr14:21372660-21372810	HEK293	kidney:	n/a	n/a
27	CTCF	chr14:21372680-21372830	HRPEpiC	eye:	n/a	n/a
28	CTCF	chr14:21402440-21402590	GM12870	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
29	CTCF	chr14:21402330-21402574	A549	lung:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
30	CTCF	chr14:21402453-21402600	GM10248	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
31	CTCF	chr14:21372681-21372816	HepG2	liver:	n/a	n/a
32	CTCF	chr14:21372720-21372870	GM12864	blood:	n/a	n/a
33	CTCF	chr14:21368259-21368289	GM13976	blood:	n/a	n/a
34	CTCF	chr14:21402313-21402630	A549	lung:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
35	CTCF	chr14:21402399-21402645	GM12891	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
36	CTCF	chr14:21372664-21372819	K562	blood:	n/a	n/a
37	CTCF	chr14:21402380-21402530	HCM	heart:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
38	CTCF	chr14:21372660-21372810	BE2_C	brain:	n/a	n/a
39	CTCF	chr14:21402367-21402657	IMR90	lung:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
40	CTCF	chr14:21402409-21402625	NHEK	skin:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
41	CTCF	chr14:21402960-21403110	GM12873	blood:	n/a	n/a
42	CTCF	chr14:21372617-21372879	K562	blood:	n/a	n/a
43	CTCF	chr14:21387762-21387795	Lung_OC	lung:	n/a	n/a
44	CTCF	chr14:21402340-21402490	MCF-7	breast:	n/a	n/a
45	CTCF	chr14:21372620-21372770	SK-N-SH_RA	brain:	n/a	n/a
46	CTCF	chr14:21402560-21402710	NB4	blood:	n/a	n/a
47	CTCF	chr14:21372521-21372908	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr14:21402480-21402630	GM12868	blood:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511
49	CTCF	chr14:21372720-21372870	MCF-7	breast:	n/a	n/a
50	CTCF	chr14:21402480-21402630	Hela-S3	cervix:	n/a	chr14:21402496-21402514 chr14:21402498-21402511 chr14:21402497-21402513 chr14:21402498-21402511

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:21386453-21386503	SK-N-MC	brain:	n/a
2	chr14:21386453-21386503	HAEpiC	amniotic membrane:	n/a
3	chr14:21386453-21386503	RPTEC	kidney:	n/a
4	chr14:21386453-21386503	NT2-D1	testis:	n/a
5	chr14:21386453-21386503	AoSMC	blood vessel:	n/a
6	chr14:21386453-21386503	BE2_C	brain:	n/a
7	chr14:21386453-21386503	HEK293	kidney:	embryo
8	chr14:21386453-21386503	CMK	blood:	n/a
9	chr14:21386453-21386503	LNCaP	prostate:	n/a
10	chr14:21386453-21386503	ProgFib	skin:	n/a
11	chr14:21386453-21386503	Jurkat	blood:	n/a
12	chr14:21386453-21386503	PANC-1	pancreas:	n/a
13	chr14:21386453-21386503	AG10803	skin:	n/a
14	chr14:21386453-21386503	HRCEpiC	kidney:	n/a
15	chr14:21386453-21386503	Hela-S3	cervix:	n/a
16	chr14:21386453-21386503	AG04449	skin:	fetal
17	chr14:21386453-21386503	HIPEpiC	eye:	n/a
18	chr14:21386453-21386503	PrEC	prostate:	n/a
19	chr14:21386453-21386503	SKMC	muscle:	n/a
20	chr14:21386453-21386503	AG09319	gingival:	n/a
21	chr14:21386453-21386503	Caco-2	colon:	n/a
22	chr14:21386453-21386503	HCPEpiC	choroid plexus:	n/a
23	chr14:21386453-21386503	U87	brain:	n/a
24	chr14:21386453-21386503	HCT-116	colon:	n/a
25	chr14:21386453-21386503	MCF10A-Er-Src	breast:	n/a
26	chr14:21386453-21386503	NB4	blood:	n/a
27	chr14:21386453-21386503	ECC-1	luminal epithelium:	n/a
28	chr14:21386453-21386503	GM12892	blood:	n/a
29	chr14:21386453-21386503	GM12878	blood:	n/a
30	chr14:21386453-21386503	Hepatocyte	liver:	n/a
31	chr14:21386453-21386503	HPAEpiC	pulmonary alveolar:	n/a
32	chr14:21386453-21386503	SK-N-SH_RA	brain:	n/a
33	chr14:21386453-21386503	GM19239	blood:	n/a
34	chr14:21386453-21386503	HCM	heart:	n/a
35	chr14:21386453-21386503	AG04450	lung:	fetal
36	chr14:21386453-21386503	GM06990	blood:	n/a
37	chr14:21386453-21386503	T-47D	breast:	n/a
38	chr14:21386453-21386503	HRPEpiC	eye:	n/a
39	chr14:21386453-21386503	HCF	heart:	n/a
40	chr14:21386453-21386503	HUVEC	blood vessel:	n/a
41	chr14:21386453-21386503	HRE	kidney:	n/a
42	chr14:21386453-21386503	HMEC	breast:	n/a
43	chr14:21386453-21386503	HNPCEpiC	eye:	n/a
44	chr14:21386453-21386503	NH-A	brain:	n/a
45	chr14:21386453-21386503	BJ	skin:	n/a
46	chr14:21386453-21386503	NHDF-neo	bronchial:	n/a
47	chr14:21386453-21386503	H1-hESC	embryonic stem cell:	embryo
48	chr14:21386453-21386503	A549	lung:	n/a
49	chr14:21386453-21386503	IMR90	lung:	fetal
50	chr14:21386453-21386503	K562	blood:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:21417758..21420748-chr14:21423705..21426897,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RNASE3-1	chr14:21387795-21388335	ENSG00000136315
2	lnc-NDRG2-2	chr14:21384925-21385029	ENSG00000258772
3	lnc-NDRG2-3	chr14:21404261-21404414	ENSG00000258918
4	lnc-RNASE2-1	chr14:21418698-21418708	NONHSAT035618
5	lnc-RNASE3-1	chr14:21387500-21387563	ENSG00000136315
6	lnc-RNASE2-1	chr14:21419045-21419476	NONHSAT035618
7	lnc-NDRG2-3	chr14:21366144-21366340	ENSG00000258918
8	lnc-NDRG2-2	chr14:21396396-21396739	ENSG00000258772

Variant related genes	Relation type
RNASE2	TF binding region
ENSG00000136315	TF binding region
ENSG00000258772	TF binding region
ENSG00000258918	TF binding region
RNASE2	CpG island
ENSG00000136315	CpG island
ENSG00000258772	CpG island
ENSG00000258918	CpG island

Extended variants
information (count: 1605 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:1605 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567279308	chr14:21363355-21363356	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs147488776	chr14:21363371-21363372	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs187050591	chr14:21363383-21363384	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs534297396	chr14:21363427-21363428	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs138064684	chr14:21363434-21363435	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs577500166	chr14:21363472-21363473	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs117345873	chr14:21363473-21363474	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs556624833	chr14:21363478-21363479	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs563150327	chr14:21363484-21363485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs371756405	chr14:21363491-21363492	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs576679014	chr14:21363492-21363493	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs143640888	chr14:21363497-21363498	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs560928643	chr14:21363534-21363535	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs578194979	chr14:21363563-21363564	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs547930466	chr14:21363586-21363587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs569393030	chr14:21363613-21363614	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs529699646	chr14:21363621-21363622	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs8020879	chr14:21363629-21363630	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs559849451	chr14:21363646-21363647	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147216955	chr14:21363786-21363787	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs191822438	chr14:21363830-21363831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs183620402	chr14:21363831-21363832	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs538134662	chr14:21363896-21363897	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs540301247	chr14:21363954-21363955	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs555404536	chr14:21363955-21363956	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs548237902	chr14:21364028-21364029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs186794139	chr14:21364044-21364045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs139665914	chr14:21364052-21364053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs571079475	chr14:21364074-21364075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs112199906	chr14:21364081-21364082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs544183368	chr14:21364194-21364195	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs149661559	chr14:21364199-21364200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs8005768	chr14:21364220-21364221	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs533231596	chr14:21364246-21364247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs539993697	chr14:21364343-21364344	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs8005959	chr14:21364370-21364371	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs540218093	chr14:21364371-21364372	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs576598857	chr14:21364374-21364375	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs373035466	chr14:21364386-21364387	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs556763037	chr14:21364398-21364399	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs57582365	chr14:21364413-21364414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs144460443	chr14:21364421-21364422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs562270021	chr14:21364432-21364433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs373030402	chr14:21364444-21364445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs144027791	chr14:21364455-21364456	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs559786710	chr14:21364499-21364500	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs532081030	chr14:21364551-21364552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs545535383	chr14:21364563-21364564	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs562341190	chr14:21364607-21364608	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs386775358	chr14:21364640-21364641	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cone-rod dystrophy	18421352	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Alzheimer''s disease	21482944	CNVD
Mental retardation	19951919	CNVD
Neuroblastoma	21899760	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Heart disease	21282601	CNVD
Esophageal cancer	20955586	CNVD
Neurodevelopmental disorder	22521361	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17440070	CNVD
Breast cancer	16272173	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Epilepsy	20736978	CNVD
Mental retardation	20736978	CNVD
severe speech impairment	20736978	CNVD
speech impairment	20736978	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
Cancer	20164919	CNVD
Breast cancer	21364760	CNVD
Mortal	21835882	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:116 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:21362200-21364600	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr14:21362400-21363400	Weak transcription	Monocytes-CD14+_RO01746	blood
3	chr14:21363200-21363800	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr14:21363400-21364200	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr14:21363800-21364600	Weak transcription	Primary monocytes fromperipheralblood	blood
6	chr14:21364200-21364400	Weak transcription	Monocytes-CD14+_RO01746	blood
7	chr14:21364400-21364800	Enhancers	Monocytes-CD14+_RO01746	blood
8	chr14:21364600-21365600	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr14:21364600-21365600	Enhancers	Primary neutrophils fromperipheralblood	blood
10	chr14:21364800-21365400	Weak transcription	Monocytes-CD14+_RO01746	blood
11	chr14:21365400-21365600	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr14:21365600-21372400	Weak transcription	Monocytes-CD14+_RO01746	blood
13	chr14:21370400-21370600	Enhancers	Gastric	stomach
14	chr14:21371800-21373000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr14:21371800-21375600	Enhancers	Primary monocytes fromperipheralblood	blood
16	chr14:21372400-21372600	Enhancers	Monocytes-CD14+_RO01746	blood
17	chr14:21372400-21372800	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr14:21372400-21373000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr14:21372400-21373000	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr14:21372400-21373200	Enhancers	ES-I3 Cell Line	embryonic stem cell
21	chr14:21372400-21373200	Enhancers	HUES48 Cell Line	embryonic stem cell
22	chr14:21372400-21373200	Enhancers	HUES6 Cell Line	embryonic stem cell
23	chr14:21372400-21373200	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr14:21372600-21373000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr14:21372600-21373000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr14:21372600-21373000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr14:21372600-21374600	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr14:21372600-21374800	Enhancers	Primary neutrophils fromperipheralblood	blood
29	chr14:21372800-21373200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr14:21373000-21373400	Enhancers	Monocytes-CD14+_RO01746	blood
31	chr14:21373400-21374000	Enhancers	Primary B cells from cord blood	blood
32	chr14:21373400-21374800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
33	chr14:21374800-21375400	Enhancers	Monocytes-CD14+_RO01746	blood
34	chr14:21378800-21379000	Flanking Active TSS	HepG2	liver
35	chr14:21379000-21379200	Active TSS	HepG2	liver
36	chr14:21385000-21386000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr14:21385000-21387400	Enhancers	Primary neutrophils fromperipheralblood	blood
38	chr14:21385000-21389400	Enhancers	Primary monocytes fromperipheralblood	blood
39	chr14:21385200-21387000	Enhancers	Monocytes-CD14+_RO01746	blood
40	chr14:21385400-21385800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr14:21386000-21386200	Enhancers	Primary hematopoietic stem cells short term culture	blood
42	chr14:21386000-21386400	Enhancers	Fetal Intestine Large	intestine
43	chr14:21386400-21387400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
44	chr14:21387000-21387800	Enhancers	Primary hematopoietic stem cells	blood
45	chr14:21387000-21388400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr14:21387000-21388400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
47	chr14:21387000-21388600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr14:21387400-21387600	Enhancers	Adipose Nuclei	Adipose
49	chr14:21387400-21387800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
50	chr14:21387400-21388000	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links